Ki Tae Suk

Author PubWeight™ 33.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. Korean J Hepatol 2008 1.70
2 Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population. Dig Dis Sci 2012 1.55
3 Catheter-free method is sufficient for preparation for transnasal endoscopy: randomized controlled trial. Dig Endosc 2013 1.42
4 Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol 2013 1.35
5 Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology 2012 1.23
6 Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 2009 1.10
7 Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol 2009 1.04
8 Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol 2015 1.02
9 Upgrade of Lesions Initially Diagnosed as Low-Grade Gastric Dysplasia upon Forceps Biopsy Following Endoscopic Resection. Gut Liver 2011 0.94
10 Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study. Liver Int 2012 0.93
11 Secular trends in prevalence of alcohol use disorder and its correlates in Korean adults: results from Korea National Health and Nutrition Examination Survey 2005 and 2009. Subst Abus 2012 0.91
12 Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 2008 0.90
13 Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol 2012 0.88
14 Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. Food Chem Toxicol 2013 0.87
15 Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea. Clin Mol Hepatol 2012 0.84
16 Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver 2012 0.83
17 Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2014 0.82
18 [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model]. Korean J Hepatol 2008 0.82
19 Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient? Hepatogastroenterology 2013 0.82
20 Liver abscess due to Klebsiella pneumoniae: risk factors for metastatic infection. Scand J Infect Dis 2013 0.82
21 Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B. J Clin Gastroenterol 2011 0.81
22 Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. J Pediatr Endocrinol Metab 2012 0.80
23 Characteristics of nonvariceal upper gastrointestinal hemorrhage in patients with chronic kidney disease. World J Gastroenterol 2013 0.80
24 PKCδ as a regulator for TGFβ1-induced α-SMA production in a murine nonalcoholic steatohepatitis model. PLoS One 2013 0.80
25 [Inhibitory effect of angiotensin II receptor antagonist on the contraction and growth of hepatic stellate cells]. Korean J Gastroenterol 2003 0.80
26 Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci 2013 0.79
27 Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication. Gut Liver 2012 0.79
28 Biomarkers of liver fibrosis. Adv Clin Chem 2013 0.77
29 Mosapride treatment for functional dyspepsia: a meta-analysis. J Gastroenterol Hepatol 2015 0.77
30 The Impact of Body Mass Index as a Predictive Factor of Steatocholecystitis. Hepatogastroenterology 2014 0.77
31 Levosulpiride, (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxybenzamide, enhances the transduction efficiency of PEP-1-ribosomal protein S3 in vitro and in vivo. BMB Rep 2011 0.77
32 Clinical impact of body mass index on bactibilia and bacteremia. BMC Gastroenterol 2014 0.77
33 Diagnostic value of multiple biomarker panel for prediction of significant fibrosis in chronic hepatitis C. Clin Biochem 2011 0.76
34 Efficacy of partial endoscopic submucosal dissection with polypectomy of gastric neoplasm during a learning period. Hepatogastroenterology 2014 0.76
35 Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. Scand J Gastroenterol 2014 0.76
36 Upper reference limits for aminotransferase activities and the prevalence of elevated aminotransferase activities in a Korean population. J Clin Gastroenterol 2013 0.76
37 An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study. Medicine (Baltimore) 2016 0.75
38 [A case of sepsis and acute renal failure associated with salmonella enterocolitis]. Korean J Gastroenterol 2008 0.75
39 Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine (Baltimore) 2017 0.75
40 Refinement of reference limits for alanine aminotransferase in the Korean elderly population. Clin Biochem 2012 0.75
41 Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals. J Clin Gastroenterol 2016 0.75
42 [Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis]. Korean J Gastroenterol 2004 0.75